SCHEMBL6089720

SCHEMBL6089720

C#Cc1cccc(OCOCCOC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 9/20 0.41
▸ ILK Q13418 5/20 0.41
▸ ERBB2 P04626 3/20 0.41
▸ GAK O14976 2/20 0.41
▸ PLK4 O00444 1/20 0.41
▸ CIT O14578 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ EPHB6 O15197 1/20 0.41
▸ SLC22A1 O15245 1/20 0.41
▸ DAPK3 O43293 1/20 0.41
▸ RIPK2 O43353 1/20 0.41
▸ BUB1 O43683 1/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ RPS6KA4 O75676 1/20 0.41
▸ STK17B O94768 1/20 0.41
▸ STK10 O94804 1/20 0.41
▸ SLCO2B1 O94956 1/20 0.41
▸ ABCB11 O95342 1/20 0.41
▸ ABL1 P00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30924197 0.89 EGFR (0.46) EGFRILKERBB2GAKPLK4
SCHEMBL2971332 0.89 EGFR (0.46) EGFRILKERBB2GAKPLK4
SCHEMBL6358005 0.87 FFAR1 (0.37) EGFRILKERBB2GAKPLK4
SCHEMBL4750637 0.84 TBXAS1 (0.46) —
SCHEMBL1772406 0.79 EGFR (0.45) EGFRILKLMNACYP3A4MAPK1
SCHEMBL13645864 0.79 DRD2 (0.50) CYP3A4CYP1A2CYP2D6MAPK1CYP2C19
SCHEMBL6089644 0.78 APP (0.41) CYP1A2CYP2D6MAPK1CYP2C19CTNNB1
SCHEMBL6087766 0.78 CHRNB2 (0.53) CYP3A4CYP1A2CYP2D6MAPK1CYP2C19
SCHEMBL9369921 0.77 KCNA3 (0.50) CYP1A2CYP2C19CA2ALDH1A1
SCHEMBL12251491 0.76 TP53 (0.53) LMNACYP3A4FGFR2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005440-B1 Therapeutic uses of tri-aryl acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2006-02-28 — — US disclosed
EP-1177176-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 — — EP disclosed
WO-2000064876-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 — — WO disclosed
Send feedback